Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Rule 8.3- Minster Pharma PLC

13 Jan 2010 14:27

RNS Number : 4922F
VFT Ltd
13 January 2010
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

VFT LTD

Company dealt in

MINSTER PHARMA PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORDINARY SHARES

Date of dealing

3/3/2005 12/1/2006 14/12/2005 7/1/2010

3/1/2006 13/1/2010

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

3/3/2005

14/12/2005

3/1/2006

12/1/2006

 7/1/2010 13/1/2010

2,000

2,500

2,500

3,000

150,000

450,000

£14.21

£1.034

£1.23

£1.25

£0.058

£0.058

Total 610,000

 

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product

name, e.g.

call option 

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option

relates

(Note 7)

Exercise

price 

Type, e.g.

American,

European

etc.

Expiry

date

Option

money

paid/received

per unit (Note

5) 

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)

NO

 

Date of disclosure

13/1/10

Contact name

B LEMER

Telephone number

0207 739 6568

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETXXLFFBFFZBBK
Date   Source Headline
11th Dec 20181:21 pmRNSHolding(s) in Company
5th Dec 201811:24 amRNSHoldings in Company - Replacement
5th Dec 20189:05 amRNSHolding(s) in Company
4th Dec 20183:58 pmRNSHolding(s) in Company
4th Dec 20183:57 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSNew Business Division Within Mporium
14th Nov 20187:00 amRNSFundraising
2nd Nov 20187:00 amRNSNew strategic partnership with BPC
29th Oct 201811:24 amRNSHolding(s) in Company
3rd Oct 20187:00 amRNSUpdate on IMPACT's Sports Syncing technology
12th Sep 20187:00 amRNSBlock Admission Six Monthly Return
30th Aug 201810:04 amRNSDirector dealing
30th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNew agency agreement for IMPACT
3rd Jul 20187:00 amRNSChange of Nominated Adviser and Broker
20th Jun 20187:00 amRNSIMPACT technology used by Performics for Samsung
30th May 20188:00 amRNSGrant of options
21st May 20189:59 amRNSResult of AGM
10th May 20189:17 amRNSHolding(s) in Company
9th May 20188:47 amRNSAnnual Report and Accounts and Notice of AGM
25th Apr 20187:00 amRNSFull Year Results
16th Mar 201812:01 pmRNSBLOCK ADMISSION SIX MONTHLY RETURN
13th Mar 20189:00 amRNSAppointment of Chief Operating Officer
26th Feb 20187:00 amRNSDirector dealing
23rd Feb 20188:31 amRNSGrant of options
23rd Feb 20187:00 amRNSBoard Changes
15th Feb 201811:39 amRNSDirector dealing
5th Jan 20187:00 amRNSNew agency agreement for IMPACT
22nd Dec 20177:00 amRNSResult of Fundraising
20th Dec 201711:15 amRNSProposed Subscription
15th Dec 20177:00 amRNSNew agency agreement for IMPACT
5th Dec 20177:00 amRNSContract for Fast Web Media
28th Nov 20177:00 amRNSNew agency agreement for IMPACT
21st Nov 20177:00 amRNSNew Commercial Agreement for IMPACT
6th Nov 20178:40 amRNSHolding(s) in Company
6th Nov 20177:00 amRNSHolding(s) in Company
6th Nov 20177:00 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSAppointment of Chief Technology Officer
1st Nov 20174:20 pmRNSHolding(s) in Company
1st Nov 20173:41 pmRNSRelease from Lock-in Agreement
29th Sep 201710:20 amRNSTotal Voting Rights
15th Sep 201710:39 amRNSBLOCK ADMISSION SIX MONTHLY RETURN
8th Aug 20177:01 amRNSBoard Changes
8th Aug 20177:00 amRNSHalf-year Report
25th Jul 20179:00 amRNSNotice of Results
21st Jun 20178:00 amRNSIndustry award and commercial agreement
18th May 20171:45 pmRNSResult of AGM
4th May 20175:04 pmRNSDirector/PDMR Shareholding
24th Apr 20177:00 amRNSFull Year Results
21st Mar 20177:00 amRNSResults of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.